- Home
- / BioCardia
BioCardia
Stock Price
$2.4
2024-10-29
Market Capitalization
$8.5 M
2024-10-29
Revenue
$58 K
FY, 2024
BioCardia Summary
Company Summary
- Overview
- BioCardia is a regenerative medicine company developing therapeutics for cardiovascular diseases with unmet medical needs. It offers biotherapeutic solutions for cardiovascular disease in its CardiAMP and CardiALLO therapies.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- San Carlos, CA, US | view all locations
- Website
- http://www.biocardia.com/
- Cybersecurity rating
Table of Contents
Key People
David McClung, CFO
Debby Holmes-Higgin, VP, Clinical & Study Recruiting
LocationsView all
1 location detected
San Carlos, CA HQ
United States
125 Shoreway Rd Suite B
BioCardia Financials
Summary Financials
- Net income (FY, 2025)
- ($8.2M)
- Cash (Q1, 2026)
- $951.0K
- EBIT (FY, 2025)
- ($8.3M)
- Enterprise value
- $8.3M